China Herpes Labialis Drugs Market Report & Forecast 2021-2027

SKU ID : QYR- 19145155

No. of pages : 93

Publishing Date : 14-Sep-2021

Detailed TOC of China Herpes Labialis Drugs Market Report & Forecast 2021-2027

1 Introduction to Research & Analysis Reports
1.1 Herpes Labialis Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Herpes Labialis Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 China Herpes Labialis Drugs Overall Market Size
2.1 China Herpes Labialis Drugs Market Size: 2021 VS 2027
2.2 China Herpes Labialis Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 China Herpes Labialis Drugs Sales: 2016-2027

3 Company Landscape
3.1 Top Herpes Labialis Drugs Players in China Market
3.2 Top China Herpes Labialis Drugs Companies Ranked by Revenue
3.3 China Herpes Labialis Drugs Revenue by Companies
3.4 China Herpes Labialis Drugs Sales by Companies
3.5 China Herpes Labialis Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Herpes Labialis Drugs Companies in China Market, by Revenue in 2020
3.7 Manufacturers Herpes Labialis Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Herpes Labialis Drugs Players in China Market
3.8.1 List of Tier 1 Herpes Labialis Drugs Companies in China
3.8.2 List of Tier 2 and Tier 3 Herpes Labialis Drugs Companies in China

4 Sights by Type
4.1 Overview
4.1.1 By Type - China Herpes Labialis Drugs Market Size Markets, 2021 & 2027
4.1.2 Valacyclovir
4.1.3 Aciclovir
4.1.4 Famciclovir
4.1.5 Docosanol
4.1.6 Other
4.2 By Type - China Herpes Labialis Drugs Revenue & Forecasts
4.2.1 By Type - China Herpes Labialis Drugs Revenue, 2016-2021
4.2.2 By Type - China Herpes Labialis Drugs Revenue, 2022-2027
4.2.3 By Type - China Herpes Labialis Drugs Revenue Market Share, 2016-2027
4.3 By Type - China Herpes Labialis Drugs Sales & Forecasts
4.3.1 By Type - China Herpes Labialis Drugs Sales, 2016-2021
4.3.2 By Type - China Herpes Labialis Drugs Sales, 2022-2027
4.3.3 By Type - China Herpes Labialis Drugs Sales Market Share, 2016-2027
4.4 By Type - China Herpes Labialis Drugs Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - China Herpes Labialis Drugs Market Size, 2021 & 2027
5.1.2 External Use
5.1.3 Oral
5.1.4 Injection
5.2 By Application - China Herpes Labialis Drugs Revenue & Forecasts
5.2.1 By Application - China Herpes Labialis Drugs Revenue, 2016-2021
5.2.2 By Application - China Herpes Labialis Drugs Revenue, 2022-2027
5.2.3 By Application - China Herpes Labialis Drugs Revenue Market Share, 2016-2027
5.3 By Application - China Herpes Labialis Drugs Sales & Forecasts
5.3.1 By Application - China Herpes Labialis Drugs Sales, 2016-2021
5.3.2 By Application - China Herpes Labialis Drugs Sales, 2022-2027
5.3.3 By Application - China Herpes Labialis Drugs Sales Market Share, 2016-2027
5.4 By Application - China Herpes Labialis Drugs Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Overview
6.1.3 GSK Herpes Labialis Drugs Sales and Revenue in China Market (2016-2021)
6.1.4 GSK Herpes Labialis Drugs Product Description
6.1.5 GSK Recent Developments
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Overview
6.2.3 Novartis Herpes Labialis Drugs Sales and Revenue in China Market (2016-2021)
6.2.4 Novartis Herpes Labialis Drugs Product Description
6.2.5 Novartis Recent Developments
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Overview
6.3.3 Teva Herpes Labialis Drugs Sales and Revenue in China Market (2016-2021)
6.3.4 Teva Herpes Labialis Drugs Product Description
6.3.5 Teva Recent Developments
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Overview
6.4.3 Mylan Herpes Labialis Drugs Sales and Revenue in China Market (2016-2021)
6.4.4 Mylan Herpes Labialis Drugs Product Description
6.4.5 Mylan Recent Developments
6.5 Cadila
6.5.1 Cadila Corporation Information
6.5.2 Cadila Overview
6.5.3 Cadila Herpes Labialis Drugs Sales and Revenue in China Market (2016-2021)
6.5.4 Cadila Herpes Labialis Drugs Product Description
6.5.5 Cadila Recent Developments
6.6 Apotex
6.6.1 Apotex Corporation Information
6.6.2 Apotex Overview
6.6.3 Apotex Herpes Labialis Drugs Sales and Revenue in China Market (2016-2021)
6.6.4 Apotex Herpes Labialis Drugs Product Description
6.6.5 Apotex Recent Developments
6.7 Daewoong Pharmaceutical
6.7.1 Daewoong Pharmaceutical Corporation Information
6.7.2 Daewoong Pharmaceutical Overview
6.7.3 Daewoong Pharmaceutical Herpes Labialis Drugs Sales and Revenue in China Market (2016-2021)
6.7.4 Daewoong Pharmaceutical Herpes Labialis Drugs Product Description
6.7.5 Daewoong Pharmaceutical Recent Developments
6.8 Livzon
6.8.1 Livzon Corporation Information
6.8.2 Livzon Overview
6.8.3 Livzon Herpes Labialis Drugs Sales and Revenue in China Market (2016-2021)
6.8.4 Livzon Herpes Labialis Drugs Product Description
6.8.5 Livzon Recent Developments
6.9 Med Shine
6.9.1 Med Shine Corporation Information
6.9.2 Med Shine Overview
6.9.3 Med Shine Herpes Labialis Drugs Sales and Revenue in China Market (2016-2021)
6.9.4 Med Shine Herpes Labialis Drugs Product Description
6.9.5 Med Shine Recent Developments
6.10 Bayer
6.10.1 Bayer Corporation Information
6.10.2 Bayer Overview
6.10.3 Bayer Herpes Labialis Drugs Sales and Revenue in China Market (2016-2021)
6.10.4 Bayer Herpes Labialis Drugs Product Description
6.10.5 Bayer Recent Developments
6.11 Blistex
6.11.1 Blistex Corporation Information
6.11.2 Blistex Overview
6.11.3 Blistex Herpes Labialis Drugs Sales and Revenue in China Market (2016-2021)
6.11.4 Blistex Herpes Labialis Drugs Product Description
6.11.5 Blistex Recent Developments
6.12 Hikma
6.12.1 Hikma Corporation Information
6.12.2 Hikma Overview
6.12.3 Hikma Herpes Labialis Drugs Sales and Revenue in China Market (2016-2021)
6.12.4 Hikma Herpes Labialis Drugs Product Description
6.12.5 Hikma Recent Developments
6.13 Carmex
6.13.1 Carmex Corporation Information
6.13.2 Carmex Overview
6.13.3 Carmex Herpes Labialis Drugs Sales and Revenue in China Market (2016-2021)
6.13.4 Carmex Herpes Labialis Drugs Product Description
6.13.5 Carmex Recent Developments
6.14 Cipher
6.14.1 Cipher Corporation Information
6.14.2 Cipher Overview
6.14.3 Cipher Herpes Labialis Drugs Sales and Revenue in China Market (2016-2021)
6.14.4 Cipher Herpes Labialis Drugs Product Description
6.14.5 Cipher Recent Developments

7 China Herpes Labialis Drugs Production Capacity, Analysis
7.1 China Herpes Labialis Drugs Production Capacity, 2016-2027
7.2 Herpes Labialis Drugs Production Capacity of Key Manufacturers in China Market

8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints

9 Herpes Labialis Drugs Supply Chain Analysis
9.1 Herpes Labialis Drugs Industry Value Chain
9.2 Herpes Labialis Drugs Upstream Market
9.3 Herpes Labialis Drugs Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Herpes Labialis Drugs Distributors and Sales Agents in China Market

10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer

List of Figures, Tables and Charts Available in China Herpes Labialis Drugs Market Report & Forecast 2021-2027

List of Tables
Table 1. Key Players of Herpes Labialis Drugs in China Market
Table 2. Top Herpes Labialis Drugs Players in China Market, Ranking by Revenue (2019)
Table 3. China Herpes Labialis Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Herpes Labialis Drugs Revenue Share by Companies, 2016-2021
Table 5. China Herpes Labialis Drugs Sales by Companies, (K Pcs), 2016-2021
Table 6. China Herpes Labialis Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Herpes Labialis Drugs Price (2016-2021) & (USD/Pcs)
Table 8. Manufacturers Herpes Labialis Drugs Product Type
Table 9. List of Tier 1 Herpes Labialis Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Herpes Labialis Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Valacyclovir
Table 12. Major Manufacturers of Aciclovir
Table 13. By Type – China Herpes Labialis Drugs Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Herpes Labialis Drugs Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Herpes Labialis Drugs Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Herpes Labialis Drugs Sales (K Pcs), 2016-2021
Table 17. By Type - China Herpes Labialis Drugs Sales (K Pcs), 2022-2027
Table 18. By Application – China Herpes Labialis Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Herpes Labialis Drugs Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Herpes Labialis Drugs Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Herpes Labialis Drugs Sales (K Pcs), 2016-2021
Table 22. By Application - China Herpes Labialis Drugs Sales (K Pcs), 2022-2027
Table 23. GSK Corporation Information
Table 24. GSK Description and Major Businesses
Table 25. GSK Herpes Labialis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 26. GSK Herpes Labialis Drugs Product
Table 27. GSK Recent Developments
Table 28. Novartis Corporation Information
Table 29. Novartis Description and Major Businesses
Table 30. Novartis Herpes Labialis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 31. Novartis Herpes Labialis Drugs Product
Table 32. Novartis Recent Developments
Table 33. Teva Corporation Information
Table 34. Teva Description and Major Businesses
Table 35. Teva Herpes Labialis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 36. Teva Herpes Labialis Drugs Product
Table 37. Teva Recent Developments
Table 38. Mylan Corporation Information
Table 39. Mylan Description and Major Businesses
Table 40. Mylan Herpes Labialis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 41. Mylan Herpes Labialis Drugs Product
Table 42. Mylan Recent Developments
Table 43. Cadila Corporation Information
Table 44. Cadila Description and Major Businesses
Table 45. Cadila Herpes Labialis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 46. Cadila Herpes Labialis Drugs Product
Table 47. Cadila Recent Developments
Table 48. Apotex Corporation Information
Table 49. Apotex Description and Major Businesses
Table 50. Apotex Herpes Labialis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 51. Apotex Herpes Labialis Drugs Product
Table 52. Apotex Recent Developments
Table 53. Daewoong Pharmaceutical Corporation Information
Table 54. Daewoong Pharmaceutical Description and Major Businesses
Table 55. Daewoong Pharmaceutical Herpes Labialis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 56. Daewoong Pharmaceutical Herpes Labialis Drugs Product
Table 57. Daewoong Pharmaceutical Recent Developments
Table 58. Livzon Corporation Information
Table 59. Livzon Description and Major Businesses
Table 60. Livzon Herpes Labialis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 61. Livzon Herpes Labialis Drugs Product
Table 62. Livzon Recent Developments
Table 63. Med Shine Corporation Information
Table 64. Med Shine Description and Major Businesses
Table 65. Med Shine Herpes Labialis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 66. Med Shine Herpes Labialis Drugs Product
Table 67. Med Shine Recent Developments
Table 68. Bayer Corporation Information
Table 69. Bayer Description and Major Businesses
Table 70. Bayer Herpes Labialis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 71. Bayer Herpes Labialis Drugs Product
Table 72. Bayer Recent Developments
Table 73. Blistex Corporation Information
Table 74. Blistex Description and Major Businesses
Table 75. Blistex Herpes Labialis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 76. Blistex Herpes Labialis Drugs Product
Table 77. Blistex Recent Developments
Table 78. Hikma Corporation Information
Table 79. Hikma Description and Major Businesses
Table 80. Hikma Herpes Labialis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 81. Hikma Herpes Labialis Drugs Product
Table 82. Hikma Recent Developments
Table 83. Carmex Corporation Information
Table 84. Carmex Description and Major Businesses
Table 85. Carmex Herpes Labialis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 86. Carmex Herpes Labialis Drugs Product
Table 87. Carmex Recent Developments
Table 88. Cipher Corporation Information
Table 89. Cipher Description and Major Businesses
Table 90. Cipher Herpes Labialis Drugs Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 91. Cipher Herpes Labialis Drugs Product
Table 92. Cipher Recent Developments
Table 93. Herpes Labialis Drugs Production Capacity (K Pcs) of Key Manufacturers in China Market, 2019-2021 (K Pcs)
Table 94. China Herpes Labialis Drugs Capacity Market Share of Key Manufacturers, 2019-2021
Table 95. Herpes Labialis Drugs Market Opportunities & Trends in China Market
Table 96. Herpes Labialis Drugs Market Drivers in China Market
Table 97. Herpes Labialis Drugs Market Restraints in China Market
Table 98. Herpes Labialis Drugs Raw Materials
Table 99. Herpes Labialis Drugs Raw Materials Suppliers in China Market
Table 100. Typical Herpes Labialis Drugs Downstream
Table 101. Herpes Labialis Drugs Downstream Clients in China Market
Table 102. Herpes Labialis Drugs Distributors and Sales Agents in China Market
List of Figures
Figure 1. Herpes Labialis Drugs Product Picture
Figure 2. Herpes Labialis Drugs Segment by Type
Figure 3. Herpes Labialis Drugs Segment by Application
Figure 4. China Herpes Labialis Drugs Market Overview: 2020
Figure 5. China Herpes Labialis Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Herpes Labialis Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. Herpes Labialis Drugs Sales in China Market: 2016-2027 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Herpes Labialis Drugs Revenue in 2020
Figure 9. Valacyclovir Product Picture
Figure 10. Aciclovir Product Picture
Figure 11. Famciclovir Product Picture
Figure 12. Docosanol Product Picture
Figure 13. Other Product Picture
Figure 14. By Type - China Herpes Labialis Drugs Sales Market Share, 2016-2027
Figure 15. By Type - China Herpes Labialis Drugs Revenue Market Share, 2016-2027
Figure 16. By Type - China Herpes Labialis Drugs Price (USD/Pcs), 2016-2027
Figure 17. External Use
Figure 18. Oral
Figure 19. Injection
Figure 20. By Application - China Herpes Labialis Drugs Sales Market Share, 2016-2027
Figure 21. By Application - China Herpes Labialis Drugs Revenue Market Share, 2016-2027
Figure 22. By Application - China Herpes Labialis Drugs Price (USD/Pcs), 2016-2027
Figure 23. GSK Herpes Labialis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Novartis Herpes Labialis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Teva Herpes Labialis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Mylan Herpes Labialis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Cadila Herpes Labialis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Apotex Herpes Labialis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Daewoong Pharmaceutical Herpes Labialis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Livzon Herpes Labialis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Med Shine Herpes Labialis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Bayer Herpes Labialis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Blistex Herpes Labialis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Hikma Herpes Labialis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Carmex Herpes Labialis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Cipher Herpes Labialis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. China Herpes Labialis Drugs Production Capacity (K Pcs), 2016-2027
Figure 38. Herpes Labialis Drugs Industry Value Chain
Figure 39. Marketing Channels

Keyplayers in China Herpes Labialis Drugs Market Report & Forecast 2021-2027

GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Med Shine
Bayer
Blistex
Hikma
Carmex
Cipher
market Reports market Reports